chrisvoncsefalvay/vaers-outcomes huggingface dataset:
26JUN pt devel h/a, nauseated, runny nose, sore throat, aching, itching during evening hrs; 27JUN itching, rash all over body, hives; Tx Decadron IM, DPH; 29JUN Solumedrol & medrol, Seldane;
MILD HEADACHE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 203A21A,expiry: UNKNOWN) dose was not reported, administered on 09-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAY-2021, the subject experienced mild headache. On 13-MAY-2021, the subject experienced low grade fever. Laboratory data included: Body temperature (NR: not provided) 99.3 F. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from low grade fever, and mild headache. This report was non-serious.
Patient stated 2 hours after receiving flu vaccine became dizzy, had nausea, fever, felt weak. Patient stated no fever on 10/23/12 still felt weak. Patient wife on phone stated he was still dizzy too no complaint of nausea on 10.23.12.
Light headache - weakness - low grade fever on 4-22-2010 on waking up. I was very tired, sleepy and weak. Slept most of the day. Woke up only to use bathroom. Tried to do some work but could not get motivated. After 4:30 pm started to feel better. Area where injection was given was hot to touch and about 1 1/2 in in diameter was bright red. Redness disappeared after 8 days.
Pt admitted to Hospital with fever, cough, and worsening dyspnea from COVID-19. Tested positive on 2/22/22. Pt states that he is fully vaccinated for COVID. Pt has history of lung transplant and is on immunosuppressive therapy. Unable to obtain manufacturer or date information of vaccine at this time.
12 hours after the second dose, If felt like I was coming down with flu, over the next 12 hours I was running a fever that would range between 101 and 103 and was very sick, hurt all over, and had over chills, in fact I had 5 layers of clothes on while I was in bed under a thick feather blanket.  3 day fever was down to 100/101 fo most of the day. Still having unusual headaches, up until today, mainly at night effecting my sleep and early in the morning.
Date of Hospitalization: 7/29/2021  2:41 PM     CC: Cough and more weak    The below information was obtained directly from the patient and the below portions of the epic record was reviewed and confirmed with the patient.   Patient is an 80-year-old male, who states that the reason for coming into the ER cough  was increased weakness.  Had a cold-like symptoms more weakness.  Patient has been trying to stay out of the public not doing much but on Sunday he went to his mother's birthday and lots of family members were present.  From that party two other people have turned positive for Covid.   + nausea -patient did have an episode of vomiting today yellow emesis did have 2 episodes of incontinence.  This is unlikely the patient's baseline.    ASSESSMENT/PLAN:   SARS-CoV-2  viral pneumonia/COVID-19: POA Dexamethasone 6 mg daily for total of 10 days   No need for repeat Covid test -to confirm negative.   Appropriate PPE was used to see the patient daily (N95, gown, gloves)    Elevated lactic acid - POA - IV hydration and follow    Diabetes mellitus type 2 POA -start on insulin per protocol   Hyperlipidemia POA   Hypertension POA   Obesity BMI 39 POA   Acute on Chronic DVT POA - started on Xarelto on 7/23    DVT prophalaxsis - Xarelto      We will hospitalized this patient to the Hospitalist's service, with the diagnosis of SARS Covid viral pneumonia and fully vaccinated patient. The patients current condition is serious.  The patient requires Hospitalization because of treatment of SARS Covid. The patient is a FULL CODE. The anticipated duration of length of stay will be 3-5 days.
Information has been received regarding a case in litigation from a lawyer via paralegal articles concerning a 6 year old female child with enterovirus infection who in approximately January 2001, was vaccinated with PEDVAXHIB (OMPC) (manufacturer unknown) (lot # not reported).  Concomitant suspect therapy included DTaP (manufacturer unknown).  Subsequently the patient experienced seizure and Kawasaki disease.  The outcome was unknown.  Upon internal review seizure was determined to be an other important medical event.  No further information is available.
Was very weak with strange headache that has still never gone away over a month later, lightheaded or faint feeling almost constantly.  I am still very tired.  I just want to feel good again.
The day following vaccine started to have chills and a headache. Saturday woke up with chest and back red "like a sunburn". Went away the next day following use of aloe vera.
Pt experience severe muscle pain 14 hours post vaccination. 3am in morning until 6pm next day. Vaccination adm 1pm 11/14/14. Pt stated no redness, swelling or bruising. Pt took MOTRIN and applied ice.
measles-like rash @ 10 days; no fever; complete recovery; no sequelae;
facial swelling; eyes started to swell; she broke out in hives over her body.; Caller reports that around 11:30 p.m. she experienced a numbing sensation in her bottom lip. When caller woke up at 2:30 a.m. her lip was swollen & numbness continued (top and bottom).; This is a spontaneous report from a non-contactable consumer or other non hcp.    A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, dose 1 via an unspecified route of administration on 10Feb2021 13:00 (Lot number and expiry date was not reported) as a single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that around 11:30 p.m. that around 11:30 p.m. she experienced a numbing sensation in her bottom lip. When caller woke up at 2:30 a.m. her lip was swollen & numbness continued (top and bottom). Patent took Benadryl, with no results. She contacted her HCP the next day and was advised to go to the ER. During that time her eyes started to swell. Patient was treated at the ER with a steroid injection and advised to not take the second vaccine. Improvement noted after treatment. About thirty hours later facial swelling started back. Patient took more Benadryl. She contacted her HCP and was advised to get an Epi Pen. On 26Feb2021 she started to have numbness in her lip and her top lip was completely swollen. The next day patient reports she broke out in hives over her body. Outcome of the events Hypoesthesia oral was not recovered, sweling face, Urticaria was unknown, Eye swelling was recovering.  Follow-up (31Mar2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation below mentioned query response.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Client felt dizzy and lightheaded. Offered food and water. Placed in gravity chair. Monitored for additional 30 min.
Dose 1 : 30Mar2021Dose 2: 13Apr2021; Fever; chills; light headaches; lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 17:45 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Mar2021 at 17:30 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 14Apr2021 at 10:00, the patient experienced fever and chills starting about 20 hours after vaccination, some light headaches and lightheadedness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever, chills, light headaches, lightheadedness were not recovered at the time of report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
15 min after injections, pt could feel pain in arm from medicine.  Arm became stiff  4 hours post injection.  Pt fell 3 years ago and muscles in L/arm (same muscles) have deteriorated from fall.  Same day, nausea off and on for 2 days.
Pain in left arm at injection site lasting for months developing into Bursitis.  Steroid injection completed with some re-leaf in April. Increase pain with decrease range of motion in October being followed up by physician with further testing.
26 hrs-52hrs after shot ran fever 102-100.5 even with advil, felt like I,'d been hit by a truck. Could not go to work. hard hot swelling, painful arm for full 5 days although I could lift my arm through the pain
hearing impaired; Initial information received on 30-Aug-2021 regarding an unsolicited valid serious case received from a consumer/non-health care professional.  This case involves an 8-month-old female patient who experienced hearing impaired (hypoacusis) after receiving DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient past medical treatment included Noctec.  The patient past vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious hearing impaired (hypoacusis) (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. This event was assessed as medically significant.  Caller states she almost died when she was 8 months from a medication called Adacel. It caused hearing loss as well.  It was reported it was spoke from attached document who should not get the vaccine to emphasize the contraindications. Encouraged caller to reach out to HCP (health care professional) with ingredient list for the comimaty vaccine so they can help compare ingredients.   It was unknown if there were lab data/results available.  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received any corrective treatment for the event (hearing impaired).  At time of reporting, the outcome was unknown for the event hearing impaired.  Information on the batch number was requested.; Sender's Comments: This case involves an 8-month-old female patient who experienced hypoacusis after vaccination with ADACEL. The time to onset is unknown. There is no further information regarding patient's medical condition at time of vaccination, history and laboratory tests ruling out alternate etiologies. Based upon the reported information, the role of a vaccine cannot be assessed.
This spontaneous report as received from a male patient of an unknown age referring to himself. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On an unknown date, the patient's physician recommended that he received a booster dose of RECOMBIVAX HB injection, for prophylaxis (exact dose, frequency, route of administration, lot# and expiration date were unknown).
Patient receive COVID vaccine 1, went to observation area and "jerking upper and lower extremities" after sitting.  Code Assist called, patient was hypertensive at 182/108, with saturations of 100% on RA.  Was transported to Urgent Care in same facility.  By that time, she was alert, appropriate, seemed to have a left facial droop.  Secondary to apparent seizure and hypertension, decision to transport by 911 was made.  Patient did leave the Urgent Care area with paramedics but later decided to go home instead.  She spoke with her primary care provider today, 2/5/21..  At that time patient revealed that she was taking  zonisamide but not keppra, as prescribed
Facial droop and numbness on left side of face.  Symptoms started morning of 02/27/2021 and continue as of today 03/03/2021.
fever; chills; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 061E21A and 014M204) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). In October 2021, PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   The chills, fever and fatigue were lasted for 24 hours.  No treatment information was provided by the reporter.  The patient received her second Moderna COVID-19 vaccine booster dose on 12-Apr-2022 (lot number 002M21A and expiration date was not available). The patient received the vaccine in her left arm and the patient reported no side effects after second booster dose.   This case was linked to MOD-2022-580230, MOD-2021-023951 (Patient Link).
Adverse event: swelling and pain on right side of neck. Constant fever, tiredness and irregular menstruation. Treatment: steroids and antibiotics outcome: slight improvement
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 06-AUG-2009, patient received improperly stored VARIVAX dose 2, from lot # 664468/0684Y (dose and expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Hard to breath,  itching .. hot feeling  from  left arm area spread to neck face head. Itchying all over, pins and needles feeling in my hands, numbness in lips ear cheek , headache neck pain.  Tiredness.
Rapid heartbeat within one minute; This is a spontaneous report from a contactable consumer (patient). A 62-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6206, expiry date was not reported) dose 1 via an unspecified route of administration at arm left on 04Mar2021 12:00 (at the age of 62-years-old) as a single dose, for covid-19 immunisation. Medical history included blood pressure from an unknown date and unknown if ongoing. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC) taken for an unspecified indication, start and stop date were not reported and blood pressure meds (both as other medications in two weeks). No other vaccine in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021 12:00 the patient experienced rapid heartbeat within one minute. The patient resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included heart rate: rapid on 04Mar2021. No treatment was given for adverse event. Outcome of the events was recovering.  No follow-up attempts are possible. No further information expected
Some flushing on 9-23-16. Increased blood pressure 159/84 and high blood sugar (up to 700) and increased heart rate on 9-24-16. Went to ER at 5 pm on 9-24-16 and sent home at 12 midnight same day. Treated with IV insulin.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. Patient's current conditions, medical history and concomitant medications was not provided. On 03-SEP-2015, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX with (lot # K021935, expiration date 10-NOV-2015 or lot # L019130, expiration date 27-MAY-2015) that was improperly stored. The reporter could not specify the lot number of (Oka/Merck) VARIVAX was administered additionally to the patient. It was reported that these dose were administered following an excursion of 14F from 28-AUG-2015 to 17-NOV-2015. No adverse effects was reported. This is one of 3 reports from the same reporter. Additional information has been requested.
Arm swollen and very red; Initial information was received on 19-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves adult and unknown gender patient who experienced arm swollen and very red (inflammation) after receiving INFLUENZA VACCINE.  The patient's past vaccination(s) included INFLUENZA VACCINE first one in 1964 and every year since.  Past medical treatment(s) concomitant medication and family history were not provided.  The patient had no medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious arm swollen and very red (inflammation) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was reported "Wonder what was in the that one".   There were no lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  Patient was recovered from event on an unknown date its about 3 days.  There will be no information available on the batch number for this case.
EYESIGHT IS A LITTLE BLURRY; BLEEDING GUMS WHEN BRUSHING TEETH; LIKE A BLISTER; PAIN IN LEG; This spontaneous report received from a patient concerned a 49 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and other pre-existing medical conditions included the patient was healthy and fit. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prevention of covid-19 vaccine. No concomitant medications were reported. On APR-2021, the subject experienced like a blister. On APR-2021, the subject experienced pain in leg. On an unspecified date, the subject experienced eyesight is a little blurry, and bleeding gums when brushing teeth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in leg, eyesight is a little blurry, bleeding gums when brushing teeth, and like a blister. This report was non-serious.
Patient is a 58-year-old female complains of shortness of breath.  She has had Covid since at least November 22 when she tested positive.  Since then she has had persistent shortness of breath which is much worse with activity.  No chest pain or fevers or chills or cough.
Flu-like sx. Pharyngitis. Peak temperature of 103.3 one day s/p immunization. Pt had been ill the previous day. Pt lost 48 hours of duty.
p/vax pt turned white, faint, cold, clammy, blue lips, nauseated, heart fast & went weak in arms but kept talking;
increasing @ site of pneumococcal vax lt arm muscle soreness, rash, swollen @ inj site;underarm (lymph nodes);can't raise arm completely;possible fever last evening;
Pt was given incorrect vaccination. Pt was properly screened prior to vaccination. Pt is over the age of 50 years and was given the LAIV Flumist vaccination which is licensed for ages 2 years 0 49 years.
2/24/06 Sudden onset chills and fever 5 pm. 2/25/06 Generalized weakness, inability to walk 2 am. Hospital admission T=38.3, mild tenderness, no inflammation at injection site of pneumovax. 2/27/06 Erythematous rash left upper arm extending from below injection site to the elbow.
102 degree fever; Fatigue; Sever body aches; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1283) via intramuscular route of administration in the left arm on 13Jan2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), montelukast sodium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), vitamin k nos (VITAMIN K), rivaroxaban (XARELTO), simvastatin, ezetimibe (BIROW) and tiotropium bromide monohydrate (SPIRIVA) for unknown indication from an unknown date. The patient previously received aspirin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EK5730) via intramuscular route of administration in the left arm on 11Dec2020 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 18:00, the patient experienced 102-degree fever (Unspecified units), fatigue and sever body aches for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of 102-degree fever, fatigue and sever body aches for 2 days were recovered on unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
She experienced headache and fatigue for a couple of days. She took acetaminophen and rested to recover and it helped.